cardiac hypertrophy_Tg(Myh6-MYOZ2*S48P)114Ajm/0

http://metadb.riken.jp/0001625IFVBTgMyh6MYOZ2S48P114Ajm0TgMyh6MYOZ2S48P114Ajm

cardiac hypertrophy_Tg(Myh6-MYOZ2*S48P)114Ajm/0

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• transgene insertion 114, Ali J Marian
  http://metadb.riken.jp/db/mgi_rdf/MGI:5581486

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Tg(Myh6-MYOZ2*S48P)114Ajm/0

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Tg(Myh6-MYOZ2*S48P)114Ajm

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: FVB

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• cardiac hypertrophy
  http://purl.obolibrary.org/obo/MP_0001625

文献

http://purl.org/net/cito/citesAsAuthority

• Alessandra. Ruggiero, et.al., Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity., Cardiovascular research, 2013, 97
  http://rdf.ncbi.nlm.nih.gov/pubmed/22987565